Targeting pericytes for angiogenic therapies

Area of Science:

• Cell Biology
• Vascular Biology
• Regenerative Medicine

Background:

• Angiogenesis is critical in diseases like cancer and wound healing, requiring targeted therapies.
• Vascular pericytes are key regulators of angiogenesis, influencing both vessel formation and stability.
• Current knowledge gaps exist regarding pericyte identity, lineage, and plasticity, limiting therapeutic applications.

Purpose of the Study:

• To integrate current knowledge on pericyte functionality, expression, and regenerative potential.
• To highlight critical unanswered questions regarding pericyte phenotypic identity and lineage.
• To motivate future research for harnessing pericyte therapeutic potential in angioregulatory therapies.

Main Methods:

• Literature review and synthesis of existing data on pericyte markers and function.
• Analysis of pericyte marker expression (e.g., SMA, Desmin, NG2, PDGFR-β) across different tissues and subpopulations.
• Exploration of pericyte plasticity and potential overlaps with other cell phenotypes.

Main Results:

• Pericyte marker expression is variable, suggesting diverse subpopulations and potential phenotypic plasticity.
• Existing markers may not definitively identify all pericyte types, leading to potential misidentification.
• Understanding pericyte heterogeneity is crucial for developing effective angioregulatory strategies.

Conclusions:

• Vascular pericytes represent a promising target for therapies aimed at modulating angiogenesis.
• Further research into pericyte identity, lineage, and plasticity is essential for therapeutic advancement.
• Clarifying pericyte biology will enable the development of novel anti- or proangiogenic treatments.